GLE1 variants, critical for mRNA export, are linked to ALS in French-Canadian populations (Kaneb et al., 2015), while Nup50 polymorphisms increase sALS risk (Megat et al., 2023). Here, NUP50 is linked to amyotrophic lateral sclerosis.